dipyridamole has been researched along with Auricular Fibrillation in 33 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole 0." | 5.28 | Atrial fibrillation after intravenous dipyridamole for thallium imaging. ( Ell, PJ; Pennell, DJ, 1992) |
| "Recent trials of antiplatelet therapy for stroke prevention indicate that the combination of clopidogrel (75 mg/d) plus low-dose aspirin (75-162 mg/d) was not more effective than low-dose aspirin alone in the long-term prevention of major vascular events among patients at high risk of atherothrombotic events, nor was it more effective than oral anticoagulation in patients with atrial fibrillation." | 4.84 | Antiplatelet therapy for stroke prevention. ( Hankey, GJ, 2007) |
| " For patients who are in atrial fibrillation, have permanent pacemakers, who cannot augment their heart rate to a minimum of 85% MPHR, dipyridamole thallium is an acceptable alternative." | 4.80 | Detection and management of coronary artery disease in patients with rheumatologic disorders. ( Ghaffari, S, 1999) |
| "In 191 patients with drug refractory paroxysmal atrial fibrillation, a bolus of 12-24 mg of adenosine was administered after all 764 PVs were isolated." | 3.78 | Adenosine plus dipyridamole: a novel strategy to enhance adenosine-induced conduction recovery after pulmonary vein isolation. ( De Potter, TJ; Eisenberger, M; Geelen, P; McCann, C; Peytchev, P, 2012) |
| "Within a cross-sectional study, nested in a cohort we identified 931 patients with a recent ischemic stroke or TIA who were discharged with OAC or with one of the antiplatelet medications aspirin, clopidogrel, or the combination of aspirin and extended-release dipyridamole." | 3.71 | Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry. ( Lalouschek, W; Lang, W; Müllner, M, 2001) |
| "(1) In the acute phase of ischaemic stroke in patients free of thrombogenic heart disease, combined treatment with aspirin + moderate-dose unfractionated heparin reduces the risk of relapse and death." | 3.70 | Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention. ( , 2000) |
| "Transient atrial fibrillation is sometimes observed following adenosine administration and adenosine is known to shorten atrial action potential duration and refractory period." | 3.69 | Effects of adenosine on atrial refractoriness and arrhythmias. ( Belardinelli, L; Buchanan, LV; Gibson, JK; Kabell, G, 1994) |
| "Thirty patients (18 women, 12 men) with permanent or paroxysmal atrial fibrillation were treated with a new antiplatelet drug, ticlopidine, in order to study platelet aggregation behaviour, to see whether the drug prevents thromboembolisms and to observe side-effects over a period of 6 months." | 3.67 | Platelet aggregation behaviour in patients treated with ticlopidine. ( Balbarini, A; Evangelisti, L; Gherarducci, G; Giordani, R; Mariani, M; Petronio, AS; Preti, R, 1987) |
| "This prospective study included 12 paroxysmal atrial fibrillation (AF) patients (61 ± 12 years; nine men) who underwent PVI at the first procedure." | 2.78 | Impact of low-dose dipyridamole injection on adenosine test after pulmonary vein isolation. ( Hachiya, H; Hirao, K; Iesaka, Y; Kusa, S; Miyazaki, S; Nakamura, H; Taniguchi, H; Uchiyama, T, 2013) |
| "About 80% of strokes have ischemic origin." | 2.43 | [Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke]. ( Szapáry, L, 2005) |
| "Stroke is a devastating complication in patients with prosthetic valves, but characterization of its late occurrence from a large cohort is lacking." | 1.32 | Late incidence and determinants of stroke after aortic and mitral valve replacement. ( Bédard, PJ; Goldstein, WG; Hendry, PJ; Masters, RG; Mesana, TG; Pipe, AL; Rubens, FD; Ruel, M, 2004) |
| "Among 801 patients not receiving treatment for thromboembolism, the annual rate was 0." | 1.30 | [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy]. ( , 1998) |
| "Dipyridamole 0." | 1.28 | Atrial fibrillation after intravenous dipyridamole for thallium imaging. ( Ell, PJ; Pennell, DJ, 1992) |
| "Aspirin was used by 91 physicians (36." | 1.28 | Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. ( Kutner, M; Nixon, G; Silverstone, F, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (27.27) | 18.7374 |
| 1990's | 8 (24.24) | 18.2507 |
| 2000's | 10 (30.30) | 29.6817 |
| 2010's | 5 (15.15) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Cortigiani, L | 1 |
| Carpeggiani, C | 1 |
| Landi, P | 1 |
| Raciti, M | 1 |
| Bovenzi, F | 1 |
| Picano, E | 1 |
| Miyazaki, S | 1 |
| Taniguchi, H | 1 |
| Uchiyama, T | 1 |
| Kusa, S | 1 |
| Nakamura, H | 1 |
| Hachiya, H | 1 |
| Hirao, K | 1 |
| Iesaka, Y | 1 |
| Jadidi, AS | 1 |
| Arentz, T | 1 |
| Fabiaña, N | 1 |
| Ramaswami, AP | 1 |
| Ang, ES | 1 |
| De Silva, DA | 1 |
| Ikeda, E | 1 |
| Kasai, T | 1 |
| Kajimoto, K | 1 |
| Miyauchi, K | 1 |
| Kubota, N | 1 |
| Kurata, T | 1 |
| Amano, A | 1 |
| Daida, H | 1 |
| Chaturvedi, S | 1 |
| Bhattacharya, P | 1 |
| De Potter, TJ | 1 |
| Eisenberger, M | 1 |
| McCann, C | 1 |
| Peytchev, P | 1 |
| Geelen, P | 1 |
| Connolly, SJ | 1 |
| Brandts, B | 1 |
| Borchard, R | 1 |
| Dirkmann, D | 1 |
| Wickenbrock, I | 1 |
| Sievers, B | 1 |
| van Bracht, M | 1 |
| Prull, MW | 1 |
| Trappe, HJ | 1 |
| Ruel, M | 1 |
| Masters, RG | 1 |
| Rubens, FD | 1 |
| Bédard, PJ | 1 |
| Pipe, AL | 1 |
| Goldstein, WG | 1 |
| Hendry, PJ | 1 |
| Mesana, TG | 1 |
| Szapáry, L | 1 |
| Kishimoto, C | 1 |
| Yoshida, Y | 1 |
| Zen, E | 1 |
| Nakamura, R | 1 |
| Ito, K | 1 |
| Han, ZX | 1 |
| Ma, GY | 1 |
| Ma, CM | 1 |
| Hankey, GJ | 1 |
| MacKellar, A | 1 |
| Kabell, G | 1 |
| Buchanan, LV | 1 |
| Gibson, JK | 1 |
| Belardinelli, L | 1 |
| Gibbs, CR | 1 |
| Li-Saw-Hee, FL | 1 |
| Lip, GY | 1 |
| Dyken, ML | 1 |
| Ghaffari, S | 1 |
| Lalouschek, W | 1 |
| Lang, W | 1 |
| Müllner, M | 1 |
| Pennell, DJ | 1 |
| Ell, PJ | 1 |
| Dalen, JE | 1 |
| Kutner, M | 1 |
| Nixon, G | 1 |
| Silverstone, F | 1 |
| Petronio, AS | 1 |
| Evangelisti, L | 1 |
| Preti, R | 1 |
| Gherarducci, G | 1 |
| Balbarini, A | 1 |
| Giordani, R | 1 |
| Mariani, M | 1 |
| Nuñez, L | 1 |
| Pinto, AG | 1 |
| Larrea, JL | 1 |
| Gil Aguado, M | 1 |
| Connor, FO | 1 |
| Dale, J | 1 |
| Nitter-Hauge, S | 1 |
| Schley, G | 1 |
| Meesmann, W | 1 |
| Kochsiek, K | 1 |
| Tauchert, M | 1 |
| Heiss, W | 1 |
| Strauer, BE | 1 |
| Sonntag, H | 1 |
| Brugger, A | 1 |
| Salvá, JA | 1 |
| Oliver, R | 1 |
| Sullivan, JM | 1 |
| Harken, DE | 1 |
| Gorlin, R | 1 |
| Botti, G | 1 |
| Visioli, O | 1 |
| Ambanelli, U | 1 |
6 reviews available for dipyridamole and Auricular Fibrillation
| Article | Year |
|---|---|
New insights in antiplatelet therapy for patients with ischemic stroke.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; I | 2011 |
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
Topics: Aspirin; Atrial Appendage; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Dipyridamole; | 2003 |
[Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; | 2005 |
Antiplatelet therapy for stroke prevention.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel | 2007 |
Antiplatelet agents and stroke prevention.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipy | 1998 |
Detection and management of coronary artery disease in patients with rheumatologic disorders.
Topics: Atrial Fibrillation; Cardiac Catheterization; Coronary Disease; Dipyridamole; Dobutamine; Echocardio | 1999 |
4 trials available for dipyridamole and Auricular Fibrillation
| Article | Year |
|---|---|
Impact of low-dose dipyridamole injection on adenosine test after pulmonary vein isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Dipyridamole; Dose-Response Relationship, Drug; Drug Interacti | 2013 |
[Prevention of embolism due to chronic auricular fibrillation with persantin (dipyridamole) combined with aspirin].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Dipyridamole; Embolism | 2007 |
Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Hu | 1998 |
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
Topics: Adult; Aortic Valve; Atrial Fibrillation; Dipyridamole; Embolism; Female; Follow-Up Studies; Heart V | 1968 |
23 other studies available for dipyridamole and Auricular Fibrillation
| Article | Year |
|---|---|
Prognostic Value of Heart Rate Reserve in Patients with Permanent Atrial Fibrillation during Dipyridamole Stress Echocardiography.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Coronary Artery Disease; Dipyridamole; Echocardiograph | 2020 |
Adenosine effect reinforced by dipyridamol: a better test to detect incomplete pulmonary vein isolation?
Topics: Adenosine; Atrial Fibrillation; Dipyridamole; Female; Humans; Male; Pulmonary Veins | 2013 |
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; | 2015 |
Dipyridamole therapy improves long-term survival after complete revascularization in patients with impaired cardiac function: a propensity analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Atrial Fibrillation; Coronary Artery Bypass; Dipyridamole; Fem | 2008 |
Adenosine plus dipyridamole: a novel strategy to enhance adenosine-induced conduction recovery after pulmonary vein isolation.
Topics: Adenosine; Aged; Atrial Fibrillation; Catheter Ablation; Chi-Square Distribution; Dipyridamole; Elec | 2012 |
Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.
Topics: Acetylcholine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Atrial Fu | 2003 |
Late incidence and determinants of stroke after aortic and mitral valve replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Cerebral | 2004 |
[Dipyridamole-induced regular R-R intervals in a case of old myocardial infarction with atrial fibrillation-flutter].
Topics: Atrial Fibrillation; Atrial Flutter; Dipyridamole; Electrocardiography; Heart; Heart Block; Humans; | 2006 |
Surgeon on bypass.
Topics: Angina Pectoris; Atrial Fibrillation; Coronary Artery Bypass; Dipyridamole; General Surgery; Halluci | 1984 |
Effects of adenosine on atrial refractoriness and arrhythmias.
Topics: Action Potentials; Adenosine; Animals; Atrial Fibrillation; Dipyridamole; Dogs; Dose-Response Relati | 1994 |
[Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dipyridamole; Female; Heart Diseases; Humans; Male; Mi | 1998 |
Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
Topics: Anticoagulants; Arrhythmia, Sinus; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Dipyridamole | 2000 |
Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; | 2001 |
Atrial fibrillation after intravenous dipyridamole for thallium imaging.
Topics: Atrial Fibrillation; Dipyridamole; Electrocardiography; Heart; Humans; Male; Middle Aged; Myocardial | 1992 |
Atrial fibrillation and embolic stroke.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Embolism; Humans; Warfa | 1991 |
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Cerebrovascu | 1991 |
Platelet aggregation behaviour in patients treated with ticlopidine.
Topics: Adult; Aged; Aspirin; Atrial Fibrillation; Bleeding Time; Dipyridamole; Female; Humans; Male; Middle | 1987 |
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therap | 1986 |
Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination | 1986 |
[Effect of dipyridamol on the fibrillation threshold of the heart prior to and following acute coronary occlusion].
Topics: Acute Disease; Animals; Atrial Fibrillation; Coronary Disease; Dipyridamole; Dogs; Heart | 1974 |
[Influence of auricular fibrillation on the coronary reserve. Studies before and following cardioversion].
Topics: Adult; Atrial Fibrillation; Coronary Circulation; Coronary Vessels; Dipyridamole; Electric Countersh | 1971 |
[Effects of dipyridamole on the refractory period of the AV node].
Topics: Animals; Atrial Fibrillation; Dipyridamole; Dogs; Heart Conduction System; Humans; Injections, Intra | 1969 |
[On the anti-arrhythmia activity of a new adrenergic blocking agent].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Digitalis Glycosides; Dipyridam | 1966 |